Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae.

Constanza NúñezAnnegrett PalavecinoIván A GonzálezPaulina DreyseChristian Erick Palavecino

Published in: Pharmaceutics (2021)

The aPDI effectively inhibits clinical isolates of K. pneumoniae, including the riskier strains of ESBL-producing bacteria and the K2+, ybtS+, and allS+ genotype. The aPDI with PSIR-3 is synergistic with Cfx.

Keyphrases

klebsiella pneumoniae
photodynamic therapy
escherichia coli
multidrug resistant
fluorescence imaging
cancer therapy
respiratory tract
drug delivery